Dr. Larry Kwak, MD, PhD, MD Anderson Cancer Center Interview Date: September 26, 2014

 Dr. Larry Kwak describes his remarkable work to create the very ultimate in personalized myeloma immunotherapy - a vaccine tailored to each myeloma patient's particular genetic signature. He describes how it works: some of the tumor cells are pulled out, purified and then packaged with a protein or immune system stimulant and given back to the patient, making it the first and only truly individualized treatment option. He notes that vaccines are best used when patients have a very low tumor burden and describes how this vaccine is being used in a clinical trial along with T cells and autologous stem cell transplant at MD Anderson.  Learn more about this very unique and exciting advance in myeloma care.    The live mPatient Myeloma Radio podcast with Dr. Larry Kwak, MD, PhD